« Back to Record
Citation APA

Degré, D., Vanwolleghem, T., Dastis, S. N., Gustot, T., Geerts, A., van Steenkiste, C., De Galocsy, C., Lepida, A., Orlent, H., Moreno, C., Serste, T., Lasser, L., Delwaide, J., Starkel, P., Laleman, W., Langlet, P., Reynaert, H., & Bourgeois, S. (2017). Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: A real-world experience from Belgium. PloS one, 12(1), e0170933. doi:10.1371/journal.pone.0170933


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247821

Degré, D., Vanwolleghem, T., Dastis, S. N., Gustot, T., Geerts, A., van Steenkiste, C., De Galocsy, C., Lepida, A., Orlent, H., Moreno, C., Serste, T., Lasser, L., Delwaide, J., Starkel, P., Laleman, W., Langlet, P., Reynaert, H., & Bourgeois, S. (2017). Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: A real-world experience from Belgium. PloS one, 12(1), e0170933. doi:10.1371/journal.pone.0170933